|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 160 out of 160 for Hccs

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.028s

Categories

Category: Publication
Type Details Score
Publication
First Author: Park US
Year: 2000
Journal: Gene
Title: Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
Volume: 251
Issue: 1
Pages: 73-80
Publication
First Author: Kaizu H
Year: 2000
Journal: Anticancer Res
Title: Gamma-ray induced hepatocarcinogenesis in p53-deficient mice.
Volume: 20
Issue: 3A
Pages: 1545-9
Publication
First Author: Miyasaka K
Year: 1995
Journal: Mol Carcinog
Title: Frequent loss of heterozygosity on chromosome 4 in diethylnitrosamine-induced C3H/MSM mouse hepatocellular carcinomas in culture.
Volume: 13
Issue: 1
Pages: 37-43
Publication
First Author: Miyasaka K
Year: 1996
Journal: Biol Pharm Bull
Title: Allelotype analysis in mouse hepatocellular carcinomas; frequent homozygous deletion of mouse homolog of p16/CDKN2 gene on chromosome 4 in culture.
Volume: 19
Issue: 5
Pages: 683-91
Publication
First Author: Cao G
Year: 1997
Journal: Gastroenterology
Title: Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer.
Volume: 112
Issue: 2
Pages: 501-10
Publication
First Author: Romach EH
Year: 1997
Journal: Mol Carcinog
Title: Altered gene expression in spontaneous hepatocellular carcinomas from male B6C3F1 mice.
Volume: 19
Issue: 1
Pages: 31-8
Publication
First Author: Thomas CD
Year: 2003
Journal: Magn Reson Med
Title: Morphological and carbogen-based functional MRI of a chemically induced liver tumor model in mice.
Volume: 50
Issue: 3
Pages: 522-30
Publication
First Author: Calvisi DF
Year: 2004
Journal: Carcinogenesis
Title: Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
Volume: 25
Issue: 6
Pages: 901-8
Publication
First Author: Okada H
Year: 2005
Journal: Int J Oncol
Title: Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas.
Volume: 26
Issue: 2
Pages: 369-77
Publication
First Author: Arsura M
Year: 2005
Journal: Cancer Lett
Title: Nuclear factor-kappaB and liver carcinogenesis.
Volume: 229
Issue: 2
Pages: 157-69
Publication
First Author: Stahl S
Year: 2005
Journal: Hepatology
Title: Genotype-phenotype relationships in hepatocellular tumors from mice and man.
Volume: 42
Issue: 2
Pages: 353-61
Publication
First Author: Liedtke C
Year: 2005
Journal: Gastroenterology
Title: Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.
Volume: 129
Issue: 5
Pages: 1602-15
Publication
First Author: Feo F
Year: 2006
Journal: Biochim Biophys Acta
Title: Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition.
Volume: 1765
Issue: 2
Pages: 126-47
Publication
First Author: Campbell JS
Year: 2007
Journal: Differentiation
Title: Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis.
Volume: 75
Issue: 9
Pages: 843-52
Publication
First Author: Niehof M
Year: 2008
Journal: Gastroenterology
Title: EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas.
Volume: 134
Issue: 4
Pages: 1191-202
Publication
First Author: Hill-Baskin AE
Year: 2009
Journal: Hum Mol Genet
Title: Diet-induced hepatocellular carcinoma in genetically predisposed mice.
Volume: 18
Issue: 16
Pages: 2975-88
Publication
First Author: Kakehashi A
Year: 2010
Journal: Toxicol Appl Pharmacol
Title: Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions.
Volume: 242
Issue: 1
Pages: 47-55
Publication
First Author: Amann T
Year: 2010
Journal: Am J Pathol
Title: Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth.
Volume: 176
Issue: 3
Pages: 1433-42
Publication
First Author: Kim HK
Year: 2011
Journal: Arch Biochem Biophys
Title: Effect of CCS on the accumulation of FALS SOD1 mutant-containing aggregates and on mitochondrial translocation of SOD1 mutants: implication of a free radical hypothesis.
Volume: 509
Issue: 2
Pages: 177-85
Publication
First Author: Allen JW
Year: 2011
Journal: FEBS J
Title: Cytochrome c biogenesis in mitochondria--Systems III and V.
Volume: 278
Issue: 22
Pages: 4198-216
Publication
First Author: Duong FH
Year: 2014
Journal: Carcinogenesis
Title: Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53.
Volume: 35
Issue: 1
Pages: 114-22
Publication
First Author: Zheng F
Year: 2015
Journal: PLoS Genet
Title: Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets.
Volume: 11
Issue: 2
Pages: e1004873
Publication
First Author: Zhang S
Year: 2018
Journal: Am J Pathol
Title: Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans.
Volume: 188
Issue: 4
Pages: 995-1006
Publication
First Author: Yim SY
Year: 2018
Journal: Mol Cancer Res
Title: Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer.
Volume: 16
Issue: 11
Pages: 1713-1723
Publication
First Author: Ruiz de Galarreta M
Year: 2019
Journal: Cancer Discov
Title: β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma.
Volume: 9
Issue: 8
Pages: 1124-1141
Publication
First Author: Thieringer FR
Year: 2012
Journal: Mol Carcinog
Title: Liver-specific overexpression of matrix metalloproteinase 9 (MMP-9) in transgenic mice accelerates development of hepatocellular carcinoma.
Volume: 51
Issue: 6
Pages: 439-48
Publication
First Author: Qiao Y
Year: 2019
Journal: Hepatology
Title: Axis inhibition protein 1 (Axin1) Deletion-Induced Hepatocarcinogenesis Requires Intact β-Catenin but Not Notch Cascade in Mice.
Volume: 70
Issue: 6
Pages: 2003-2017
Publication
First Author: Iguchi E
Year: 2020
Journal: Sci Rep
Title: DNA methyltransferase 3B plays a protective role against hepatocarcinogenesis caused by chronic inflammation via maintaining mitochondrial homeostasis.
Volume: 10
Issue: 1
Pages: 21268
Publication
First Author: Liu M
Year: 2016
Journal: Hepatology
Title: CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors.
Volume: 63
Issue: 5
Pages: 1544-59
Publication
First Author: Craig AJ
Year: 2021
Journal: PLoS Genet
Title: Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma.
Volume: 17
Issue: 6
Pages: e1009589
Publication
First Author: Molina-Sánchez P
Year: 2020
Journal: Gastroenterology
Title: Cooperation Between Distinct Cancer Driver Genes Underlies Intertumor Heterogeneity in Hepatocellular Carcinoma.
Volume: 159
Issue: 6
Pages: 2203-2220.e14
Publication
First Author: Wang C
Year: 2012
Journal: J Hepatol
Title: Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways.
Volume: 57
Issue: 3
Pages: 577-83
Publication
First Author: Chen RY
Year: 2021
Journal: Cell Death Dis
Title: CPAP enhances and maintains chronic inflammation in hepatocytes to promote hepatocarcinogenesis.
Volume: 12
Issue: 11
Pages: 983
Publication
First Author: Wang H
Year: 2021
Journal: Cell Death Dis
Title: Distinct functions of transforming growth factor-β signaling in c-MYC driven hepatocellular carcinoma initiation and progression.
Volume: 12
Issue: 2
Pages: 200
Publication
First Author: Ellis JM
Year: 2012
Journal: Toxicol Pathol
Title: Mice deficient in glycerol-3-phosphate acyltransferase-1 have a reduced susceptibility to liver cancer.
Volume: 40
Issue: 3
Pages: 513-21
Publication
First Author: Wang B
Year: 2014
Journal: Hepatology
Title: Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2.
Volume: 59
Issue: 2
Pages: 555-66
Publication  
First Author: Cannito S
Year: 2023
Journal: Biosci Rep
Title: Inflammatory processes involved in NASH-related hepatocellular carcinoma.
Volume: 43
Issue: 1
Publication
First Author: Hanley KL
Year: 2022
Journal: Mol Cancer Res
Title: Concurrent Disruption of the Ras/MAPK and NF-κB Pathways Induces Circadian Deregulation and Hepatocarcinogenesis.
Volume: 20
Issue: 3
Pages: 337-349
Publication
First Author: Li X
Year: 2023
Journal: J Biol Chem
Title: Hepatocyte-specific Wtap deficiency promotes hepatocellular carcinoma by activating GRB2-ERK depending on downregulation of proteasome-related genes.
Volume: 299
Issue: 11
Pages: 105301
Publication
First Author: Peloso A
Year: 2023
Journal: PLoS One
Title: Portosystemic shunting prevents hepatocellular carcinoma in non-alcoholic fatty liver disease mouse models.
Volume: 18
Issue: 12
Pages: e0296265
Publication
First Author: Santoni-Rugiu E
Year: 1998
Journal: Cancer Res
Title: Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Volume: 58
Issue: 1
Pages: 123-34
Publication
First Author: Santoni-Rugiu E
Year: 1999
Journal: Am J Pathol
Title: Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
Volume: 154
Issue: 6
Pages: 1693-700
Publication
First Author: Liu JJ
Year: 2018
Journal: J Hepatol
Title: Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET.
Volume: 69
Issue: 1
Pages: 79-88
Publication
First Author: Feng GJ
Year: 2012
Journal: Gastroenterology
Title: Conditional disruption of Axin1 leads to development of liver tumors in mice.
Volume: 143
Issue: 6
Pages: 1650-9
Publication
First Author: Tamano S
Year: 1994
Journal: Carcinogenesis
Title: Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
Volume: 15
Issue: 9
Pages: 1791-8
Publication
First Author: Teoh WW
Year: 2015
Journal: Dis Model Mech
Title: Molecular characterization of hepatocarcinogenesis using mouse models.
Volume: 8
Issue: 7
Pages: 743-53
Publication
First Author: Zhu Y
Year: 2024
Journal: Cell Death Dis
Title: ZBTB7B is a permissive regulator of hepatocellular carcinoma initiation by repressing c-Jun expression and function.
Volume: 15
Issue: 1
Pages: 55
Publication
First Author: Meyer K
Year: 2003
Journal: Carcinogenesis
Title: Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen.
Volume: 24
Issue: 5
Pages: 975-84
Publication
First Author: Gougelet A
Year: 2019
Journal: Gastroenterology
Title: Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography.
Volume: 157
Issue: 3
Pages: 807-822
Publication
First Author: Wang J
Year: 2013
Journal: J Pathol
Title: Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
Volume: 230
Issue: 4
Pages: 441-52
Publication
First Author: Stauffer JK
Year: 2011
Journal: Cancer Res
Title: Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors.
Volume: 71
Issue: 7
Pages: 2718-27
Publication
First Author: Evason KJ
Year: 2015
Journal: PLoS Genet
Title: Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish.
Volume: 11
Issue: 7
Pages: e1005305
Publication
First Author: Yang L
Year: 2013
Journal: Gastroenterology
Title: Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
Volume: 144
Issue: 5
Pages: 1042-1054.e4
Publication
First Author: Uthaya Kumar DB
Year: 2016
Journal: Gastroenterology
Title: TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.
Volume: 150
Issue: 3
Pages: 707-19
Publication
First Author: Wang F
Year: 2016
Journal: Cancer Prev Res (Phila)
Title: Transcriptome Analysis of WHV/c-myc Transgenic Mice Implicates Cytochrome P450 Enzyme 17A1 as a Promising Biomarker for Hepatocellular Carcinoma.
Volume: 9
Issue: 9
Pages: 739-49
Publication
First Author: Zhang X
Year: 2024
Journal: Cancer Res
Title: N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression.
Volume: 84
Issue: 6
Pages: 827-840
Publication
First Author: Santoni-Rugiu E
Year: 1996
Journal: Am J Pathol
Title: Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Volume: 149
Issue: 2
Pages: 407-28
Publication
First Author: Aziz K
Year: 2019
Journal: Gastroenterology
Title: Ccne1 Overexpression Causes Chromosome Instability in Liver Cells and Liver Tumor Development in Mice.
Volume: 157
Issue: 1
Pages: 210-226.e12
Publication  
First Author: Sengupta D
Year: 2020
Journal: Mol Metab
Title: Regulation of hepatic glutamine metabolism by miR-122.
Volume: 34
Pages: 174-186
Publication
First Author: Weiler SME
Year: 2017
Journal: Gastroenterology
Title: Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
Volume: 152
Issue: 8
Pages: 2037-2051.e22